DPC in Primary Molars.

• Status: Completed
• Trial end date: 2020-12-01
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate clinical and radiographical outcomes of direct pulp capping using calcium hydroxide (CH), mineral trioxide aggregate (MTA), and premedicated direct pulp capping (PDPC) with formocresol (FC) in primary teeth.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Mansoura University
• Treatments: Calcium

Criteria

Inclusion Criteria:

1. Absence of chronic systemic disease and any type of medical treatment or continues use of any medication.

2. Absence of drug allergies, anesthetics, and environmental allergies.

3. Cooperative patients.

4. Restorable teeth with deep decay lesions.

5. Teeth with signs of reversible pulpitis; no spontaneous pain; and absence of edema, pain, fistula, pathological mobility, and sensitivity to percussion.

6. True pinpoint exposure (small exposure surrounded by sound dentin with normal bleeding easily controlled)

7. Teeth with no pathological root resorption, periradicular or furcal radiolucency.

8. Teeth with less than one-third physiological root resorption (no resorption or one-fourth resorption of the root).

Exclusion Criteria:

• otherwise